EBA strengthens risk review of European banks’ sovereign bonds: risk exposure remains controllable
智通财经2026/10/09 07:06(1) The head of the European Banking Authority (EBA) stated that European banking regulators are conducting additional reviews regarding the risks associated with the trillions of euros in sovereign bond portfolios held by banks. (2) According to the official, as the yields on government bonds in some core European countries have soared to multi-year highs, the government debt investment portfolios held by banks require enhanced monitoring. (3) Currently, the relevant risk exposures still appear to be "within controllable ranges." (4) The net interest income generated from bonds has largely offset the impact of declining bond prices on the economic value of banks' equity. (5) He said, "So far, we have not seen banks suffer significant losses as a result of the current situation, and we are confident that regulators are taking the necessary responsive measures."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Delta Air Lines expects fourth-quarter revenue to grow by 20% year-on-year
Delta Air Lines (DAL.US) expects fourth-quarter revenue to increase by 20% year-on-year, with capacity growing by about 3%.
U.S. stocks movement | Federal Medicare Advantage Plan ratings greatly improved, Humana (HUM.US) surged nearly 12%
According to information from Zhitong Finance APP, on Friday, Humana (HUM.US) shares surged as much as 18% in early trading and were up nearly 12% at $433.07 at the time of reporting. Humana disclosed that 95% of relevant insured members have entered plans rated four stars or above. Based on the final Medicare Advantage Plan star ratings for 2027, Humana expects the average monthly star rating revenue per member to reach $160 by 2027. The company stated that this performance has exceeded its "top quartile" target, which is 10% higher than the industry average. Humana reaffirmed its guidance for adjusted earnings per share of at least $9 for fiscal year 2026.
Moderna officially included in the Nasdaq 100 Index, surges nearly 9% intraday
Moderna surged intraday, now up nearly 9%, reaching its highest stock price since December 2022. The company was officially included in the Nasdaq 100 index today.
【US Stock Market Movement】Circle surged on October 9: SAP payments + USDC expansion + stablecoins
Crypto prices
More
